Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma:: They correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation

被引:9
作者
Dong, BM
Sato, M
Sakurada, A
Sagawa, M
Endo, C
Wu, SL
Yamanaka, S
Horii, A
Kondo, T
机构
[1] Miyagi Canc Ctr, Dept Thorac Surg, Natori, Miyagi 9811293, Japan
[2] Tohoku Univ, Sch Med, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan
[3] Tohoku Univ, Sch Med, Dept Thorac Surg, Sendai, Miyagi 980, Japan
[4] Kanazawa Med Univ, Dept Thorac Surg, Kanazawa, Ishikawa, Japan
[5] Tohoku Univ, Dept Mol Pathol, Sendai, Miyagi 980, Japan
关键词
D O I
10.1016/j.jtcvs.2005.05.013
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: We previously reported that the computed tomographic M/L ratio (area of the tumor in the mediastinal computed tomographic image/area of the tumor in the lung Computed tomographic image) of small peripheral lung adenocarcinoma is correlated with patient prognosis. Methods: Immunostaining for p53, bcl-2, Ki-67, vascular endothelial growth factor, CD34, matrix rnetalloproteinase 2, matrix metalloproteinase 9, tissue inhibitor of matrix metalloprotemase 2, and mutation of K-ras was assessed in 131 surgically resected, primary peripheral lung adenocarcinomas of 30 mm or less in maximum diameter to clarify the relationship between computed tomographic findings and biologic activities. Results: The numbers of patients with high labeling indexes of Ki-67 and high expression of vascular endothelial growth factor, CD34, matrix metalloproteinase 2, and matrix metalloproteinase 9 in the solid-type group (computed tomographic M/L ratio >= 50%) were significantly higher than those in the faint density-type group (computed tomographic M/L ratio < 50%; P = .04 for Ki-67, P = .03 for vascular endothelial growth factor, P = .0009 for CD34, P = .001 for matrix metalloprotemase 2, and P = .00001 for matrix metalloproteinase 9). The number of patients with high levels of CD44v6 or tissue inhibitor of matrix metalloproteinase 2 staining in the faint density-type group was significantly higher than that in the solid-type group (P = .02 for CD44v6 and P = .01 for tissue inhibitor of matrix metalloprotemase 2). Independent variables capable of predicting computed tomographic M/L ratio included CD34, matrix metal loproteinase 2, matrix inetalloproteinase 9, and tissue inhibitor of matrix metalloproteinase 2 (P = .0093, P = .0003, P = .0027, and P = .01, respectively; binary logistic regression analysis). Conclusions: Our results suggest that the computed tomographic image of small lung adenocarcinoma is correlated with biologic activities and thus provides possible prognostic information.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 32 条
[1]
Cho JY, 1997, CANCER-AM CANCER SOC, V79, P462, DOI 10.1002/(SICI)1097-0142(19970201)79:3<462::AID-CNCR6>3.0.CO
[2]
2-K
[3]
A biological staging model for operable non-small cell lung cancer [J].
Cox, G ;
Jones, JL ;
Andi, A ;
Waller, DA ;
O'Byrne, KJ .
THORAX, 2001, 56 (07) :561-566
[4]
Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung [J].
Demarchi, LMMF ;
Martins, M ;
Palomino, SAP ;
Farhat, C ;
Takagaki, TY ;
Beyruti, R ;
Saldiva, PHN ;
Capelozzii, VL .
MODERN PATHOLOGY, 2000, 13 (05) :511-520
[5]
Computed tomographic image comparison between mediastinal and lung windows provides possible prognostic information in patients with small peripheral lung adenocarcinoma [J].
Dong, BM ;
Sato, M ;
Sagawa, M ;
Endo, C ;
Usuda, K ;
Sakurada, A ;
Wu, SL ;
Oyaizu, T ;
Ishida, I ;
Handa, M ;
Kondo, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (05) :1014-1020
[6]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[7]
K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer [J].
Fukuyama, Y ;
Mitsudomi, T ;
Sugio, K ;
Ishida, T ;
Akazawa, K ;
Sugimachi, K .
BRITISH JOURNAL OF CANCER, 1997, 75 (08) :1125-1130
[8]
Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma [J].
Higashiyama, M ;
Kodama, K ;
Yokouchi, H ;
Takami, K ;
Mano, M ;
Kido, S ;
Kuriyama, K .
ANNALS OF THORACIC SURGERY, 1999, 68 (06) :2069-2073
[9]
K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer:: a combined analysis of 881 cases [J].
Huncharek, M ;
Muscat, J ;
Geschwind, JF .
CARCINOGENESIS, 1999, 20 (08) :1507-1510
[10]
Inoshima N, 2002, CLIN CANCER RES, V8, P3480